AGL EBITDA
Agilon Health · EBITDA
AGL EBITDA
Latest reported-$234.01Mperiod ending
AGL TTM EBITDA (-$65.44M → -$234.01M)
TTM EBITDA
High-resolution chart · PNG
AGL ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -234,008,000 | |
| -340,640,000 | |
| -368,861,000 | |
| -286,593,000 | |
| -294,505,000 | |
| -221,729,000 | |
| -218,186,000 | |
| -277,215,000 | |
| -181,935,000 | |
| -167,177,000 | |
| -163,545,000 | |
| -58,237,000 | |
| -69,829,000 | |
| -78,417,000 | |
| -87,392,000 | |
| -89,835,000 | |
| -96,274,000 | |
| -371,585,000 | |
| -383,782,000 | |
| -364,117,000 | |
| -338,996,000 | |
| -45,058,000 | |
| -40,109,000 | |
| -65,443,000 |